POS-283 HEMOGLOBIN (HB) CORRECTION WITH ROXADUSTAT IS ASSOCIATED WITH IMPROVED IRON HOMEOSTASIS IN PATIENTS WITH NON-DIALYSIS-DEPENDENT (NDD) AND DIALYSIS-DEPENDENT (DD) CHRONIC KIDNEY DISEASE (CKD)

• P. Pergola,
• C. Charytan,
• D. Little,
• S. Tham,
• L. Szczech,
• R. Leong,
• S. Fishbane

Affiliations

P. Pergola

Renal Associates PA, Nephrology, San Antonio, United States

C. Charytan

New York-Presbyterian/Queens, Division of Nephrology, Flushing, United States

D. Little

AstraZeneca, Clinical Research, Gaithersburg, United States

S. Tham

AstraZeneca, Clinical Research, Gothenburg, Sweden

L. Szczech

FibroGen Inc., None, San Francisco, United States

R. Leong

FibroGen Inc., None, San Francisco, United States

S. Fishbane

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Medicine, Great Heck, United States